Report: The Millenium Development Goals 2011

Click here for full report

The United Nations (UN) released a report on July 12 on the progress made thus far on the 8 Millennium Development Goals (MDGs). The eight MDGs include: end poverty and hunger, universal education, gender equality, child health, maternal health, combat HIV/AIDS, environmental sustainability, and global partnership. To learn more about the MDGs, go to Key highlights of the report are:

Positive Impacts

  • Targeted interventions have succeeded in reducing child mortality
  • Increased funding and control efforts have cut deaths from malaria
  • Investments in preventing and treating HIV are yielding results
  • Effective strategies against tuberculosis are saving millions of lives
  • Effective strategies against tuberculosis are saving millions of lives
  • Poverty continues to decline in many countries and regions
  • Some of the poorest countries have made the greatest strides in education

Areas lagging behind

  • The poorest children have made the slowest progress in terms of improved nutrition
  • Opportunities for full and productive employment remain particularly slim for women
  • Being poor, female or living in a conflict zone increases the probability that a child will be out of school
  • Advances in sanitation often bypass the poor and those living in rural areas
  • Improving the lives of a growing number of urban poor remains a monumental challenge
  • Progress has been uneven in improving access to safe drinking water

Additional coverage: UN report paints mixed picture of global progress on MDG goals

More News
14 Aug 2019
FDA released the following press release on Wednesday, August 14th: The U.S. Food and Drug Administration today approved Pretomanid Tablets in combination with bedaquiline and linezolid for the treatment of a specific type of highly treatment-resistant tuberculosis (TB) of the lungs. “The threat of...
27 Jun 2019
-- Globe Newswire reported on June 20th -- Spero Therapeutics, Inc. , a multi-asset clinical-stage biopharmaceutical company focused on identifying, developing and commercializing treatments in high unmet need areas involving multi-drug resistant (MDR) bacterial infections and rare diseases, today...
5 Jun 2019
**Update: The US FDA Antimicrobial Drug Advisory Committee voted in favor of the NDA 14 to 4 on June 6th, 2019** The United States Food & Drug Administration (FDA) will host the Antimicrobial Drug Advisory Committee on Thursday, June 6th to discuss the new drug application (NDA) involving new...